Innovation solves disease
Thomas Peter Stossel 1-4-2017. ( Thomas Peter Stossel. "Removing barriers to medical innovation." American Enterprise Institute. Web. 1-4-2017. accessed 6-26-2017. < https://www.aei.org/publication/912939/ >. Phops)
The second era of medical innovations came in the 19th century with the establishment of universities and independent institutes in Europe, and subsequently in North America. Innovations originating from these institutions included a wide variety of revolutionary treatments: the identification and potential eradication of disease-spreading insects; effective treatments of infectious disease with antitoxins and antibiotics; vaccines to prevent diphtheria, pertussis, tetanus, and polio; anticoagulants (“blood thinners”); and vitamin and hormone-replacement therapies.
In this second innovation era, medical advances did in fact largely arise in universities and research institutes. Private industry’s role was to provide manufacturing capabilities that enabled the discoveries to benefit patients, and it was the principal source of the chemical compounds that clinicians — often in academic settings — tested for therapeutic effects.